Medical Research
GLP-1 Drugs and Alcohol: A Small Trial Hints at a Delayed Drinking Effect
A secondary analysis of a placebo-controlled trial in patients with alcohol use disorder and obesity found exenatide lowered a blood marker of drinking — but only after months, not weeks.